Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

128.29
Delayed Data
As of May 29
 +0.89 / +0.70%
Today’s Change
63.68
Today|||52-Week Range
137.50
+7.99%
Year-to-Date

Today’s Trading

Previous close127.40
Today’s open126.92
Day’s range125.67 - 128.87
Volume1,212,778
Average volume (3 months)1,701,877
Market cap$31.1B
Dividend yield--
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)-58.59%
Earnings growth (this year)+41.89%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-52.11%
P/E ratioNM
Price/Sales48.16
Price/Book28.65

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-2.35-1.41%
PRGOPerrigo Company PLC-3.66-1.89%
MYLMylan NV-0.05-0.07%
ZTSZoetis Inc+0.66+1.34%
Data as of 4:14pm ET, 05/29/2015

Financials

Next reporting dateJuly 27, 2015
EPS forecast (this quarter)-$0.76
Annual revenue (last year)$580.4M
Annual profit (last year)-$738.6M
Net profit margin-127.09%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
SVP &
GM-International Commercial Operations
Simon Bedson
Corporate headquarters
Boston, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers